Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.
Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.
The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.
Publications found:
1,430
Sort by:
Dermatologicals in South Africa
US$ 990.00
... associated with a lack of hygiene or a... Euromonitor International's Dermatologicals in South Africa report offers a comprehensive guide to the size and shape ... Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical ...
February 2020
22 pages
Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026
US$ 3,000.00
... Peptide Therapeutics, Peptide Vaccine & Peptide Hormone Global Peptide Therapeutics Market Dynamics Global Peptide Clinical Pipeline by Company, Indication & Phase Global Peptide Pipeline: 722 Peptides Majority Peptides in Preclinical Phase: 308 Peptides Commercially Available Peptides: 136 Peptides ...
January 2020
1500 pages
Proton Therapy in Cancer: Global Markets
US$ 4,950.00
REPORT SCOPE: BCC Research’s new report, “Proton Therapy in Cancer: Global Markets,” provides a comprehensive analysis of the proton therapy market in global context, including market forecasts and...
December 2019
185 pages
Therapeutic Proteins Global Market Report 2020. Including: 1) By Product Type: Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone 2) By Application: Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others. Covering: Abbott Laboratories, Amgen Inc, Baxter International Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd
US$ 4,000.00
If ordered it will be delivered within 3-5 business days. Therapeutic Proteins Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with...
December 2019
200 pages
Dermatologicals in Hong Kong, China
US$ 990.00
... The humidity and high levels of air pollution seen in Hong Kong have been associated with skin problems, including inflammatory or allergic ... to have a negative impact on skin health. Euromonitor International's Dermatologicals in Hong Kong, China report offers a comprehensive guide to the size and shape of the ...
November 2019
21 pages
Allergic Rhinitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
166 pages
Urinary Incontinence - Pipeline Review, H2 2019
US$ 2,000.00
... Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Urinary Incontinence and features dormant and discontinued projects. The guide covers therapeutics under Development ...
November 2019
72 pages
Endometriosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Endometriosis (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
134 pages
Bronchitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bronchitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
129 pages
Cystic Fibrosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Cystic Fibrosis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
489 pages
Polycystic Ovarian Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
50 pages
Sinusitis - Pipeline Review, H2 2019
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
117 pages
Anal Cancer - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Anal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
475 pages
Choroidal Neovascularization - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Choroidal Neovascularization (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Choroidal Neovascularization and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
57 pages
Pulmonary Arterial Hypertension - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
364 pages
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H2 2019
US$ 2,000.00
... Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
88 pages
Acromegaly - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
102 pages
Alopecia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
184 pages
Anthrax - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
110 pages
Cough - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Cough (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Cough and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
99 pages
Glomerulonephritis - Pipeline Review, H2 2019
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
281 pages
Neutropenia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
131 pages
Ocular Hypertension - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Ocular Hypertension (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Ocular Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
144 pages
Fragile X Syndrome - Pipeline Review, H2 2019
US$ 2,000.00
... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
172 pages
Hyperuricemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Hyperuricemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperuricemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
85 pages
Tinnitus - Pipeline Review, H2 2019
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
48 pages
Bacterial Conjunctivitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
31 pages
Myocardial Infarction - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
332 pages
Myocardial Ischemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Myocardial Ischemia (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Ischemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
87 pages
Rectal Cancer - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Rectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
186 pages
Chemotherapy Induced Neutropenia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Chemotherapy Induced Neutropenia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
137 pages
Dementia - Pipeline Review, H2 2019
US$ 2,000.00
... . The Dementia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dementia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
371 pages
Insulin Resistance - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Insulin Resistance (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Insulin Resistance and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
48 pages
Thalassemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Thalassemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thalassemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
207 pages
Leiomyosarcoma - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Leiomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
528 pages
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The B-Cell Chronic Lymphocytic Leukemia (Oncology) pipeline guide also reviews of key players involved in therapeutic development for B-Cell Chronic Lymphocytic Leukemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
190 pages
Retinopathy Of Prematurity - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
67 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2019
US$ 2,000.00
... . The Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Proliferative Diabetic Retinopathy (PDR) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
60 pages
Bone Fracture - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Bone Fracture (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Bone Fracture and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
75 pages
Batten Disease - Pipeline Review, H2 2019
US$ 2,000.00
... . The Batten Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Batten Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
November 2019
87 pages
Uveitis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
248 pages
Axillary Hyperhidrosis - Pipeline Review, H2 2019
US$ 2,000.00
... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
November 2019
47 pages
Cerebral Palsy - Pipeline Review, H2 2019
US$ 2,000.00
Cerebral Palsy - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H2 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that can ...
November 2019
44 pages
